ASSESSMENT OF OXIDATIVE STRESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CORRELATION TO HBA1C

Main Article Content

Dr. Supriya
Dr.Raksha Hebbar K
Dr M Anuswaru
Rishi KP

Keywords

TAC (total antioxidant capacity), MDA (malondialdehyde), HbA1c (glycosylated hemoglobin), Oxidative Stress, Diabetes Mellitus.

Abstract

Introduction: Diabetes mellitus is a complex disorder characterized by either insufficient insulin production or ineffective insulin action. Chronic hyperglycemia can lead to various diabetic complications, including neuropathy, nephropathy, and retinopathy. Oxidative stress is a primary factor contributing to these complications.


Aim: This study aims to assess the oxidative stress levels in patients with type 2 diabetes mellitus (type 2 DM) in comparison to healthy individuals.


Materials & Methods: The research involved 140 participants, comprising 70 individuals diagnosed with type 2 DM (Diabetic group) and 70 healthy controls (Control group). Following a thorough medical history assessment, 5 ml of venous blood was drawn from each participant in both groups and sent to a central laboratory for the evaluation of blood glucose parameters (HbA1c%, fasting blood sugar mg/dl, and postprandial blood sugar mg/dl) as well as oxidative stress markers (total antioxidant capacity in mmol/dl and malondialdehyde in mmol/dl). The collected data were analyzed using SPSS software version 23.0.


Results: The diabetic group exhibited a significant increase in HbA1c, fasting blood sugar, and postprandial blood sugar levels when compared to the healthy individuals. Furthermore, oxidative stress levels were found to be elevated in diabetic patients, indicated by an increase in mean malondialdehyde and a decrease in total antioxidant capacity (P<0.05). A strong positive correlation was observed between HbA1c and malondialdehyde.


Conclusion: The diabetic group demonstrated elevated blood glucose levels alongside increased oxidative stress. The study also established a significant correlation between glycemic levels and oxidative stress, as evidenced by the rise in malondialdehyde levels with increasing blood glucose levels.


 

Abstract 36 | PDF Downloads 14

References

1. Banerjee M, Vats P. Reactive metabolites and antioxidant gene polymorphisms in Type2 diabetes mellitus. Redox Biolog. 2014; 2:170-177.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of diabetes epidemic. Nature. 2011; 414:782-787.
3. Alexandra Kautzky-Willer, Jürgen Harreiter, Giovanni Pacini. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev.2016.37 (3):278-316.
4. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005; 59(7):365-373.
5. Whiting DR, Guariguanta L, Weil C. Shaw JEIDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94:311–21.
6. Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. Markers of oxidative stress during diabetes mellitus. J Biomark. 2013; 37:87-90.
7. Joshi SR, Parikh RM. India - diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007; 55: 323–4.
8. American Diabetes Association.2018. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 41(1), s13-s27.
9. Johansen J.S., A.K. Harris D. J. Rychly, A. Ergul, Oxidative stress and use of anti oxidants in diabetes; linking basic science to clinical practice, cardiovasc. diabetol. 2005; 4(5):1-5.
10. Faramawy EL, S.M., Rizk, R.A. Spectrophotometric studies on antioxidants-doped liposomes. J. Am. Sci. 2011; 7(7): 363–369.
11. Ayepola, O.R., Brooks, N.L., Oguntibeju, O.O.. Oxidative Stress and Diabetic Complications: The Role of Antioxidant Vitamins and Flavonoids. 2014..
12. Yoshikawa T, Naito Y. What Is Oxidative Stress? Journal of Japan Medical Association. 2002;45(7):271‒276.
13. Devasagayam T. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004;52(1) :794‒804.
14. Akinosun OM, Bolajoko EB. Total Antioxidant Status in Type 2 Diabetic Patients: Experience at University College Hospital (Uch) Ibadan, Nigeria. Nigerian Journal of Clinical Practice. 2007; 10(2):126-129.
15. Akinosun OM, Bolajoko EB. Total Antioxidant Status in Type 2 Diabetic Patients: Experience at University College Hospital (Uch) Ibadan, Nigeria. Nigerian Journal of Clinical Practice. 2007; 10(2):126-129.
16. J E Davis, Jay M Mcdonald, Leonard Jarett; A High-performance Liquid Chromatography Method for Hemoglobin A1c. Diabetes 1 February 1978; 27 (2): 102–107.
17. Meghna Borah, Rohini Kanta Goswami. Sociodemographic and clinical characteristics of a diabetic population at a tertiary care center in Assam, India. Journal of Social Health and Diabetes.2017;5(1):37-42.
18. International Diabetes Federation. IDF Diabetes Atlas, 5th ed., 2013; Brussels: Belgium.
19. Chaganti nagesh ,nilamnigam ,srawankumar , anil kumar. Study on effect of vitamin-c as add on therapy with antidiabetic drugs in newly diagnosed type-2 diabetes mellitus patients. J adv sci res, 2021; 12 (1): 66-71.
20. Jaya Prasad Tripathy, J. S. Thakur, Gursimer Jeet, Sohan Chawla, Sanjay Jain, Arnab Pal, Rajendra Prasad and Rajiv Saran. Prevalence and risk factors of diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India. Diabetol Metab Syndr 2017; 9(8):2-8.
21. Chaganti Nagesh, Anil Kumar, Srawan Kumar, Nilam Nigam. Study On Effect OfVitamin-C As Add On Therapy With Antidiabetic Drugs In Type-2 Diabetes Mellitus Patients Associated With Sod2 Gene Polymorphism. J Adv Sci Res, 2021; 12 (2): 171-177.
22. Bhalerao SD, Somannavar M, Vernikas SS, Ravishankar R, Goudar SS. Risk factors for type 2 diabetes mellitus in rural population of North Karnataka: A community-based cross-sectional study. Int J Pharma Med Biological Sci. 2014; 3(1):1-4.
23. D'Souza AM, Kundapur R, Kiran NU. A Cross-sectional study to determine the prevalence of diabetes mellitus and its household awareness in the rural field practice areas of a medical college in Mangalore-a pilot study. Nitte Uni J Health Sci. 2015;5(3):43.
24. World Health Organization. Prevention and control of Diabetes Mellitus: Report of an Inter country workshop, Dhaka, Bangladesh: WHO; 2009.
25. Little M, Humphries S, Patel K, Dodd W, Dewey C. Factors associated with glucose tolerance, pre-diabetes, and type 2 diabetes in a rural community of south India: a cross-sectional study. Diabetol Metab Syndr. 2016; 8(21):1-11.
26. Suvarna Devi C, Nishitha ganugapeta, Sai Sravan Kumar Reddythala, M. Anuswaru. Estimation of Total Antioxidant Capacity in Patients of Type-2Diabetes Mellitus in Correlation with Hba1c.journal of cardiovascular disease research. 2024. 15(05):431-438.
27. Chaganti Nagesh, Anil Kumar, Srawan Kumar, Nilam Nigam. Study On Effect OfVitamin-C As Add On Therapy With Antidiabetic Drugs In Type-2 Diabetes Mellitus Patients Associated With Sod2 Gene Polymorphism. J Adv Sci Res, 2021; 12 (2): 171-177.
28. Wang Y, Yang M, Lee SG, Davis CG, Koo SI, Chun OK. Dietary total antioxidant capacity is associated with diet and plasma antioxidant status in healthy young adults. J AcadNutr Diet. 2012; 112(10):1626-1635.
29. Pourvali K, Abbasi M and Mottaghi A. Role of Superoxide Dismutase 2 Gene Ala16Val Polymorphism and Total Antioxidant Capacity in Diabetes and its Complications. Avicenna J Med Biotech. 2016; 8(2):48 56.
30. Akinosun OM, Bolajoko EB. Total Antioxidant Status in Type 2 Diabetic Patients: Experience at University College Hospital (Uch) Ibadan, Nigeria. Nigerian Journal of Clinical Practice. 2007; 10(2):126 129.
31. Low PA. The role of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 1997; 46(2):538-542.